$MYOV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Myovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Myovant Sciences Ltd.. Get notifications about new insider transactions in Myovant Sciences Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.24 | 50,000 | 612,075 | 48,247,693 | 48.2 M to 48.2 M (+0.10 %) |
| May 07 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.69 | 50,000 | 584,465 | 48,197,693 | 48.1 M to 48.2 M (+0.10 %) |
| May 05 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.50 | 50,000 | 574,870 | 48,147,693 | 48.1 M to 48.1 M (+0.10 %) |
| May 05 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.38 | 50,000 | 569,180 | 48,097,693 | 48 M to 48.1 M (+0.10 %) |
| May 01 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.08 | 50,000 | 603,825 | 48,047,693 | 48 M to 48 M (+0.10 %) |
| May 01 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.92 | 50,000 | 595,895 | 47,997,693 | 47.9 M to 48 M (+0.10 %) |
| Apr 29 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.05 | 50,000 | 602,720 | 47,947,693 | 47.9 M to 47.9 M (+0.10 %) |
| Apr 29 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.18 | 40,503 | 493,302 | 47,897,693 | 47.9 M to 47.9 M (+0.08 %) |
| Apr 27 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.15 | 43,086 | 523,344 | 47,857,190 | 47.8 M to 47.9 M (+0.09 %) |
| Apr 27 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.35 | 35,000 | 432,103 | 47,814,104 | 47.8 M to 47.8 M (+0.07 %) |
| Apr 23 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.93 | 50,000 | 596,730 | 47,779,104 | 47.7 M to 47.8 M (+0.10 %) |
| Apr 23 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.58 | 50,200 | 581,140 | 47,729,104 | 47.7 M to 47.7 M (+0.11 %) |
| Apr 21 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.82 | 50,300 | 594,425 | 47,678,904 | 47.6 M to 47.7 M (+0.11 %) |
| Apr 21 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 10.76 | 70,000 | 753,536 | 47,628,604 | 47.6 M to 47.6 M (+0.15 %) |
| Apr 17 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 10.64 | 70,000 | 744,674 | 47,558,604 | 47.5 M to 47.6 M (+0.15 %) |
| Apr 17 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 10.48 | 70,000 | 733,698 | 47,488,604 | 47.4 M to 47.5 M (+0.15 %) |
| Apr 15 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 11.00 | 70,000 | 770,105 | 47,418,604 | 47.3 M to 47.4 M (+0.15 %) |
| Apr 15 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 9.81 | 70,000 | 686,546 | 47,348,604 | 47.3 M to 47.3 M (+0.15 %) |
| Apr 13 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 9.37 | 70,000 | 655,669 | 47,278,604 | 47.2 M to 47.3 M (+0.15 %) |
| Apr 09 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 8.53 | 70,000 | 596,939 | 47,208,604 | 47.1 M to 47.2 M (+0.15 %) |
| Apr 09 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 8.21 | 70,000 | 574,364 | 47,138,604 | 47.1 M to 47.1 M (+0.15 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Option Exercise | A | 8.08 | 302,693 | 2,445,759 | 302,693 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Grant | A | 0.00 | 197,659 | 0 | 1,043,824 | 846.2 K to 1 M (+23.36 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 8.08 | 134,464 | 1,086,469 | 134,464 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 87,805 | 0 | 146,710 | 58.9 K to 146.7 K (+149.06 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 8.08 | 170,396 | 1,376,800 | 170,396 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Grant | A | 0.00 | 111,268 | 0 | 145,865 | 34.6 K to 145.9 K (+321.61 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 8.08 | 183,991 | 1,486,647 | 183,991 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 120,146 | 0 | 163,470 | 43.3 K to 163.5 K (+277.32 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 8.08 | 134,464 | 1,086,469 | 134,464 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Grant | A | 0.00 | 87,805 | 0 | 145,115 | 57.3 K to 145.1 K (+153.21 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 8.44 | 70,000 | 590,520 | 47,068,604 | 47 M to 47.1 M (+0.15 %) |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.93 | 70,000 | 554,925 | 46,998,604 | 46.9 M to 47 M (+0.15 %) |
| Apr 03 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.73 | 70,000 | 541,086 | 46,928,604 | 46.9 M to 46.9 M (+0.15 %) |
| Apr 03 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.46 | 70,000 | 522,298 | 46,858,604 | 46.8 M to 46.9 M (+0.15 %) |
| Apr 01 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.97 | 70,000 | 557,984 | 46,788,604 | 46.7 M to 46.8 M (+0.15 %) |
| Apr 01 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.65 | 70,000 | 535,766 | 46,718,604 | 46.6 M to 46.7 M (+0.15 %) |
| Mar 30 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.98 | 70,000 | 558,250 | 46,648,604 | 46.6 M to 46.6 M (+0.15 %) |
| Mar 30 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.94 | 70,000 | 555,807 | 46,578,604 | 46.5 M to 46.6 M (+0.15 %) |
| Mar 26 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.60 | 108,100 | 821,895 | 46,508,604 | 46.4 M to 46.5 M (+0.23 %) |
| Mar 26 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.67 | 211,200 | 1,620,559 | 46,400,504 | 46.2 M to 46.4 M (+0.46 %) |
| Mar 24 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.68 | 211,200 | 1,621,932 | 46,189,304 | 46 M to 46.2 M (+0.46 %) |
| Mar 24 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.60 | 193,900 | 1,472,709 | 45,978,104 | 45.8 M to 46 M (+0.42 %) |
| Mar 20 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.68 | 193,900 | 1,488,958 | 45,784,204 | 45.6 M to 45.8 M (+0.43 %) |
| Mar 20 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.40 | 193,900 | 1,434,938 | 45,590,304 | 45.4 M to 45.6 M (+0.43 %) |
| Mar 19 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 6.93 | 15 | 104 | 58,905 | 58.9 K to 58.9 K (-0.03 %) |
| Mar 19 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 7.38 | 770 | 5,683 | 58,920 | 59.7 K to 58.9 K (-1.29 %) |
| Mar 18 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.40 | 193,900 | 1,433,949 | 45,396,404 | 45.2 M to 45.4 M (+0.43 %) |
| Mar 18 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 7.25 | 193,900 | 1,406,008 | 45,202,504 | 45 M to 45.2 M (+0.43 %) |
| Feb 24 2020 | MYOV | Myovant Sciences L ... | Gulfo Adele M. | Director | Option Exercise | A | 11.17 | 45,000 | 502,650 | 45,000 | |
| Jan 16 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 14.04 | 4,840 | 67,954 | 59,690 | 64.5 K to 59.7 K (-7.50 %) |
| Dec 31 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Sell | S | 0.00 | 45,008,604 | 0 | 0 | 45 M to 0 (-100.00 %) |
| Dec 31 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Sell | S | 0.00 | 45,008,604 | 0 | 0 | 45 M to 0 (-100.00 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 15.55 | 19,018 | 295,730 | 34,597 | 53.6 K to 34.6 K (-35.47 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 15.55 | 19,701 | 306,351 | 43,324 | 63 K to 43.3 K (-31.26 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 15.55 | 19,018 | 295,730 | 34,597 | 53.6 K to 34.6 K (-35.47 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 15.55 | 19,701 | 306,351 | 43,324 | 63 K to 43.3 K (-31.26 %) |
| Dec 19 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 16.22 | 2,585 | 41,929 | 64,530 | 67.1 K to 64.5 K (-3.85 %) |
| Dec 18 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 15.94 | 75,000 | 1,195,500 | 45,008,604 | 44.9 M to 45 M (+0.17 %) |
| Dec 18 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 15.68 | 38,459 | 603,037 | 44,933,604 | 44.9 M to 44.9 M (+0.09 %) |
| Dec 18 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 14.97 | 131,541 | 1,969,169 | 44,895,145 | 44.8 M to 44.9 M (+0.29 %) |
| Dec 04 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 17.56 | 2,529 | 44,409 | 44,763,604 | 44.8 M to 44.8 M (+0.01 %) |
| Dec 04 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 17.04 | 72,471 | 1,234,906 | 44,761,075 | 44.7 M to 44.8 M (+0.16 %) |
| Dec 04 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 18.85 | 65,525 | 1,235,146 | 44,688,604 | 44.6 M to 44.7 M (+0.15 %) |
| Dec 04 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 18.21 | 113,668 | 2,069,894 | 44,623,079 | 44.5 M to 44.6 M (+0.26 %) |
| Nov 27 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 15.00 | 3,500,000 | 52,500,000 | 44,509,411 | 41 M to 44.5 M (+8.53 %) |
| Nov 27 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 15.00 | 3,500,000 | 52,500,000 | 44,509,411 | 41 M to 44.5 M (+8.53 %) |
| Nov 22 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 12.38 | 18,293 | 226,467 | 41,009,411 | 41 M to 41 M (+0.04 %) |
| Nov 22 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 11.80 | 103,613 | 1,222,633 | 40,991,118 | 40.9 M to 41 M (+0.25 %) |
| Nov 22 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 12.90 | 121,906 | 1,572,587 | 40,887,505 | 40.8 M to 40.9 M (+0.30 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 7.78 | 66,130 | 514,491 | 66,130 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | D | 24.44 | 66,130 | 1,616,217 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 7.78 | 133,500 | 1,038,630 | 133,500 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | D | 17.28 | 133,500 | 2,306,880 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 37,415 | 0 | 67,115 | 29.7 K to 67.1 K (+125.98 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 7.78 | 152,110 | 1,183,416 | 152,110 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | D | 24.44 | 152,110 | 3,717,568 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 7.78 | 87,050 | 677,249 | 87,050 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | D | 21.87 | 87,050 | 1,903,784 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 7.78 | 310,000 | 2,411,800 | 310,000 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | D | 11.30 | 310,000 | 3,503,000 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Grant | A | 0.00 | 53,615 | 0 | 53,615 | 0 to 53.6 K |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 132,270 | 1,029,061 | 132,270 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 24.44 | 132,270 | 3,232,679 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 114,690 | 892,288 | 114,690 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 21.87 | 114,690 | 2,508,270 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 200,000 | 1,556,000 | 200,000 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 12.68 | 200,000 | 2,536,000 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 55,025 | 0 | 63,025 | 8 K to 63 K (+687.81 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 66,130 | 514,491 | 66,130 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 66,130 | 514,491 | 66,130 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 24.44 | 66,130 | 1,616,217 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 24.44 | 66,130 | 1,616,217 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 87,050 | 677,249 | 87,050 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 87,050 | 677,249 | 87,050 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 21.87 | 87,050 | 1,903,784 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 21.87 | 87,050 | 1,903,784 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 260,000 | 2,022,800 | 260,000 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 7.78 | 260,000 | 2,022,800 | 260,000 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 10.60 | 260,000 | 2,756,000 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | D | 10.60 | 260,000 | 2,756,000 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Grant | A | 0.00 | 47,570 | 0 | 57,310 | 9.7 K to 57.3 K (+488.40 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Grant | A | 0.00 | 47,570 | 0 | 57,310 | 9.7 K to 57.3 K (+488.40 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | GUINAN MARK | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | GUINAN MARK | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
| Jun 14 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Buy | P | 8.96 | 4,500 | 40,320 | 5,000 | 500 to 5 K (+900.00 %) |
| Jun 14 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Buy | P | 8.92 | 300 | 2,676 | 500 | 200 to 500 (+150.00 %) |
| Jun 14 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Buy | P | 8.93 | 100 | 893 | 200 | 100 to 200 (+100.00 %) |
| Jun 14 2019 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Buy | P | 8.95 | 100 | 895 | 100 | 0 to 100 |
| Jun 13 2019 | MYOV | Myovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 13 2019 | MYOV | Myovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 11 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | P | 9.10 | 8,000 | 72,800 | 8,000 | 0 to 8 K |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 06 2019 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 24.44 | 66,130 | 1,616,217 | 66,130 | |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 24.44 | 152,110 | 3,717,568 | 152,110 | |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 24.44 | 66,130 | 1,616,217 | 66,130 | |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 24.44 | 132,270 | 3,232,679 | 132,270 | |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Option Exercise | A | 24.44 | 330,660 | 8,081,330 | 330,660 | |
| Feb 20 2019 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 21.15 | 260 | 5,499 | 9,740 | 10 K to 9.7 K (-2.60 %) |
| Dec 18 2018 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 17.28 | 133,500 | 2,306,880 | 133,500 | |
| Dec 18 2018 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 29,700 | 0 | 29,700 | 0 to 29.7 K |
| Nov 08 2018 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 22.83 | 45,000 | 1,027,350 | 45,000 | |
| Sep 24 2018 | MYOV | Myovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 26.17 | 45,000 | 1,177,650 | 45,000 | |
| Sep 04 2018 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 24.25 | 22,500 | 545,625 | 22,500 | |
| Sep 04 2018 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 24.25 | 22,500 | 545,625 | 22,500 | |
| Sep 04 2018 | MYOV | Myovant Sciences L ... | Altmeyer Mark | Director | Option Exercise | A | 24.25 | 22,500 | 545,625 | 22,500 | |
| Jul 24 2018 | MYOV | Myovant Sciences L ... | GUINAN MARK | Director | Option Exercise | A | 19.71 | 45,000 | 886,950 | 45,000 | |
| Jun 15 2018 | MYOV | Myovant Sciences L ... | Altmeyer Mark | Director | Buy | P | 13.38 | 3,500 | 46,830 | 3,500 | 0 to 3.5 K |
| Apr 18 2018 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 21.87 | 87,050 | 1,903,784 | 87,050 | |
| Apr 18 2018 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Option Exercise | A | 21.87 | 248,450 | 5,433,602 | 248,450 | |
| Apr 18 2018 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 21.87 | 114,690 | 2,508,270 | 114,690 | |
| Apr 18 2018 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 21.87 | 87,050 | 1,903,784 | 87,050 | |
| Apr 05 2018 | MYOV | Myovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |